EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Psychotropic Prescribing Patterns Among Bipolar‐I Patients Prior to Established Bipolar‐I Disorder Diagnosis

Filmon Haile iD, Clayton English iD, Kyueun Lee

Bipolar Disorders · 2026-08 · 28 (5)

DOI: 10.1111/bdi.70137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bipolar Disorders, online erschienen am 30.06.2026. Verfasst von Filmon Haile und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, CHOICE Institute, University of Washington, School of Pharmacy, Seattle, WA, USA. Hauptthemen laut MEDLINE: Bipolar Disorder, Practice Patterns, Physicians', Psychotropic Drugs. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Bipolar I Disorder (BP‐I) is frequently misdiagnosed as Major Depressive Disorder (MDD), delaying appropriate treatment. This study aimed to examine treatment patterns among BP‐I patients misdiagnosed with MDD and assess the impact of these regimens on the time until BP‐I diagnosis.

Methods

A retrospective cohort study was conducted using the MarketScan Commercial Claims and Encounters database, analyzing 21,771 BP‐I patients initially misdiagnosed with MDD and 50,667 correctly diagnosed BP‐I patients. Treatment patterns and their influence on time to BP‐I diagnosis were assessed using multinomial logistic regression and Cox proportional hazards models.

Results

Among the misdiagnosed cohort, 25.1% were initially started on antidepressant monotherapy, with 8.7% continuing this regimen after BP‐I diagnosis. In contrast, 7.6% of the initially BP‐I diagnosed cohort received antidepressant monotherapy. The time to BP‐I conversion was shortest for those on mood stabilizer monotherapy (HR: 1.26, 95% CI: 1.19–1.34, p < 0.001), compared to those on antidepressant monotherapy. After BP‐I diagnosis, patients originally misdiagnosed with MDD had different prescribing patterns, exhibiting lower rates of guideline‐consistent treatments. Specifically, patients initially diagnosed with BP‐I were more likely to receive mood stabilizing therapy, either as monotherapy (OR = 2.63, p < 0.001) or in combination with an antidepressant (OR = 1.84, p < 0.001).

Conclusion

Misdiagnosis of BP‐I as MDD leads to significant delays in accurate diagnosis and inappropriate treatment regimens, highlighting the critical need for improved diagnostic accuracy at initial presentation. Prompt and accurate BP‐I diagnosis can optimize treatment approaches and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderPractice Patterns, Physicians'Psychotropic DrugsHumansFemaleMaleRetrospective StudiesAdultMiddle AgedMajor Depressive DisorderAntidepressive AgentsDiagnostic ErrorsCohort StudiesYoung Adult

Substanzen

Antidepressive AgentsPsychotropic Drugs

Autor:innen und Institutionen

  • Department of Pharmacy, CHOICE Institute, University of Washington, School of Pharmacy, Seattle, WA, USA.

ORCID-Profile: Filmon Haile, Clayton English

Zitieren

APA

Haile, F., English, C., & Lee, K. (2026). Psychotropic Prescribing Patterns Among Bipolar‐I Patients Prior to Established Bipolar‐I Disorder Diagnosis. Bipolar Disorders, 28(5). https://doi.org/10.1111/bdi.70137

Vancouver

Haile F, English C, Lee K. Psychotropic Prescribing Patterns Among Bipolar‐I Patients Prior to Established Bipolar‐I Disorder Diagnosis. Bipolar Disorders. 2026;28(5). doi:10.1111/bdi.70137

BibTeX
@article{Haile2026,
  author = {Haile, Filmon and English, Clayton and Lee, Kyueun},
  title = {Psychotropic Prescribing Patterns Among Bipolar‐I Patients Prior to Established Bipolar‐I Disorder Diagnosis},
  journal = {Bipolar Disorders},
  year = {2026},
  volume = {28},
  number = {5},
  doi = {10.1111/bdi.70137}
}
Kostenlos starten →